v.231201
Showing details for project SYSMHC00071
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
|---|---|---|---|---|---|
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
| SYSMHC00071_20161021_Maver | 5 | Human | DRB1_0101,DRB1_1301,DRB3_0202,HLA-DQA10101-DQB10501,HLA-DQA10103-DQB10603 | ||
| SYSMHC00071_20161213_Maver | 5 | Human | DRB1_0101,DRB1_1301,DRB3_0202,HLA-DQA10101-DQB10501,HLA-DQA10103-DQB10603 | ||
| SYSMHC00071_20170123_Maver | 5 | Human | DRB1_0101,DRB1_1301,DRB3_0202,HLA-DQA10101-DQB10501,HLA-DQA10103-DQB10603 | ||
| SYSMHC00071_20170705_DR_HLA2_L243_M | 1 | Human | DRB1_0301,DRB1_1301,HLA-DQA10110-DQB10201,HLA-DQA10501-DQB10603 | ||
| SYSMHC00071_20170706_DR_HLA2_L243_M | 1 | Human | DRB1_0701,DRB1_1104,HLA-DQA10201-DQB10202,HLA-DQA10505-DQB10301 | ||
| SYSMHC00071_20170711_DR_HLA2_L243_M | 1 | Human | DRB1_0101,DRB1_1102,HLA-DQA10101-DQB10301,HLA-DQA10505-DQB10501 | ||
| SYSMHC00071_20170712_DR_HLA2_L243_M | 3 | Human | DRB1_0301,DRB1_1104,HLA-DQA10501-DQB10201,HLA-DQA10505-DQB10301 | ||
| SYSMHC00071_20170719_DR_HLA2_L243_M | 3 | Human | DRB1_0101,DRB1_1501,DRB5_0101,HLA-DQA10101-DQB10501,HLA-DQA10102-DQB10602 | ||
| SYSMHC00071_20170722_DR_HLA2_L243_M | 3 | Human | DRB1_0101,DRB1_1501,DRB5_0101,HLA-DQA10101-DQB10501,HLA-DQA10102-DQB10602 |
Detailed view of sample SYSMHC00071_20170712_DR_HLA2_L243_M
| ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
| SYSMHC00071 | SYSMHC00071_20170712_DR_HLA2_L243_M | 20170712_DR_HLA2_SPVL3_M1_DDA_1.raw | Human | In vitro | Blood | Maver-1 | suspension | class II | DRB1_0301,DRB1_1104,HLA-DQA10501-DQB10201,HLA-DQA10505-DQB10301 | MSV000081729 | native | Immunoaffinity | SPV-L3 | Q-Exactive | no | DDA | HCD | 0-30% ACN | 120 | 1 | ||||
| SYSMHC00071 | SYSMHC00071_20170712_DR_HLA2_L243_M | 20170712_DR_HLA2_SPVL3_M1_DDA_2.raw | Human | In vitro | Blood | Maver-1 | suspension | class II | DRB1_0301,DRB1_1104,HLA-DQA10501-DQB10201,HLA-DQA10505-DQB10301 | MSV000081729 | native | Immunoaffinity | SPV-L3 | Q-Exactive | no | DDA | HCD | 0-30% ACN | 120 | 2 | ||||
| SYSMHC00071 | SYSMHC00071_20170712_DR_HLA2_L243_M | 20170712_DR_HLA2_SPVL3_M1_DDA_3.raw | Human | In vitro | Blood | Maver-1 | suspension | class II | DRB1_0301,DRB1_1104,HLA-DQA10501-DQB10201,HLA-DQA10505-DQB10301 | MSV000081729 | native | Immunoaffinity | SPV-L3 | Q-Exactive | no | DDA | HCD | 0-30% ACN | 120 | 3 |